Camrelizumab Combination With SBRT and Concurrent Chemotherapy Treated Stage IV Oligometastatic Non-small Cell Lung Cancer
Clinical trial NCT05472467 · UNKNOWN
Trial details
- NCT number
- NCT05472467
- Sponsor
- Sichuan Cancer Hospital and Research Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-21
- Primary completion
- 2023-12-20
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.